Gail A. Spiridigliozzi, PhD
- Psychiatry / Medical Psychology
- Pediatrics
Address
DUMC 3364
Durham, NC 27710
Appointment Telephone
919-668-4485
Office Telephone
919-668-5559
Fax Telephone
919-668-4496
- PhD, Clinical Child Psychology, University of Kansas, 1988
- Clinical Child Psychology, North Carolina Memorial Hospital at Chapel Hill, 1984-1985, 1987-1989
Clinical Interests
School-aged children with developmental and learning issues, including learning disabilities, mental retardation, fragile X syndrome, attention deficit/hyperactivity disorder, and autism; academically gifted children
Research Interests
Cholinergic therapy in children and adolescents with Down syndrome; premutation carriers of fragile X syndrome; cognitive development of children with infantile-onset Pompe disease who are being treated with enzyme replacement therapy.
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Pfizer Inc.
- Roche
Representative Publications
Kishnani PS, Sommer BR, Handen BL, Seltzer B, Capone GT, Spiridigliozzi GA, Heller JH, Richardson S, McRae T. The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. Am J Med Genet A. 2009 Jul 15;149A(8):1641-1654.
(2009)
Abstract
McConkie-Rosell A, Heise EM, Spiridigliozzi GA. Genetic risk communication: experiences of adolescent girls and young women from families with fragile X syndrome. J Genet Couns. 2009 Aug;18(4):313-25.
(2009)
Abstract
Wehbe RM, Spiridigliozzi GA, Heise EM, Dawson DV, McConkie-Rosell A. When to tell and test for genetic carrier status: perspectives of adolescents and young adults from fragile X families. Am J Med Genet A. 2009 Jun;149A(6):1190-9.
(2009)
Abstract
McConkie-Rosell A, Spiridigliozzi GA, Melvin E, Dawson DV, Lachiewicz AM. Living with genetic risk: effect on adolescent self-concept. Am J Med Genet C Semin Med Genet. 2008 Feb 15;148C(1):56-69.
(2008)
Abstract
Spiridigliozzi GA, Heller JH, Crissman BG, Sullivan-Saarela JA, Eells R, Dawson D, Li J, Kishnani PS. Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: a clinical report series. Am J Med Genet A. 2007 Jul 1;143A(13):1408-13.
(2007)
Abstract
Heller JH, Spiridigliozzi GA, Crissman BG, Sullivan JA, Eells RL, Li JS, Doraiswamy PM, Krishnan KR, Kishnani PS. Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study. J Child Adolesc Psychopharmacol. 2006 Dec;16(6):755-65.
(2006)
Abstract
Heller JH, Spiridigliozzi GA, Crissman BG, Sullivan-Saarela JA, Li JS, Kishnani PS. Clinical trials in children with Down syndrome: issues from a cognitive research perspective. Am J Med Genet C Semin Med Genet. 2006 Aug 15;142C(3):187-95.
(2006)
Abstract
Lachiewicz AM, Dawson DV, Spiridigliozzi GA, McConkie-Rosell A. Arithmetic difficulties in females with the fragile X premutation. Am J Med Genet A. 2006 Apr 1;140(7):665-72.
(2006)
Abstract
